Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING (Tables)

v3.21.2
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
SCHEDULE OF INFORMATION ABOUT REPORTED SEGMENT PROFIT OR LOSS AND ASSETS

 

    Breast           COVID-19        
    Cancer Test     Alzheimer     Testing     Total  
   

Unaudited

 
Nine months ended September 30, 2021                        
Revenues     -       -       7,773       7,773  
Operating loss     (4,685 )     -       (996 )     (5,681 )
Unallocated amounts:                                
Financing expenses, net                             (17,368 )
Share in losses of affiliated companies accounted for under equity method, net                                 (1,499 )
Net loss                             (24,547 )
Total Assets     10,257       -       6,904       17,161  
Other significant items:                                
Total expenditures for assets of reportable segment     2       -       933       935  
Total depreciation for reportable segment     (22 )     -       (504 )     (526 )
SUMMARY OF REVENUES BY GEOGRAPHIC REGION

 

   

Nine months

period ended

September 30,

    Three months
period ended
September 30,
    Nine

months

period ended

September 30,

    Three months period ended September 30,  
    2021     2021     2020     2020  
    Unaudited     Unaudited  
Israel   $ -     $ -   $ -     $  -  
United States     7,773       1,010       1,316       1,284  
Revenues     7,773       1,010       1,316       1,284  

SUMMARY OF PROPERTY AND EQUIPMENT, NET, BY GEOGRAPHIC AREA

 

    As of     As of  
    September 30, 2021     December 31, 2020  
    Unaudited        
Israel   $ 41     $ 61  
United States     2,550       1,938  
Property and equipment, net   $ 2,591     $ 1,999